A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populations

A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populations

Abstract Background The World Health Organisation (WHO) recommends that testing and treatment for latent tuberculosis infection (LTBI) should be undertaken in high-risk groups using either interferon gamma release assays (IGRAs) or a tuberculin skin test (TST). As IGRAs are more expensive than TST,...

Full description

Bibliographic Details
Main Authors: James Mahon, Sophie Beale, Hayden Holmes, Mick Arber, Vladyslav Nikolayevskyy, Riccardo Alagna, Davide Manissero, David Dowdy, Giovanni Battista Migliori, Giovanni Sotgiu, Raquel Duarte
Format: Article
Language:English
Published: BMC 2022-10-01
Series:BMC Pulmonary Medicine
Subjects:
Tuberculosis
Systematic Review
Cost-effectiveness
Cost-utility
Testing
Online Access:https://doi.org/10.1186/s12890-022-02149-x

Internet

https://doi.org/10.1186/s12890-022-02149-x

Similar Items